On the 1st of June 2023, the METRINO project—Metrology for Nanotherapeutics—commenced its groundbreaking journey. Launching with an inaugural meeting at the scenic LNE site in Paris, this initiative marks a significant stride in the field of nanomedicine. Our collaborative effort aims to redefine the standardization and characterization landscape in this vital and growing sector.
METRINO, funded by EURAMET – The European Association of National Metrology Institutes, is spearheading the development of traceable measurement methods and reference materials. Our primary focus is on evaluating the quality of innovative nanotherapeutics, such as synthetic lipid-based nanoparticles like liposomes and LNPs-RNA, as well as metal oxide nanoparticles. Under the coordination of Fanny Caputo from LNE, METRINO endeavors to position Europe at the forefront of metrology in nanomedicine.
The METRINO project’s kickoff meeting was held in the marvelous building of the Laboratoire National d’Essais (LNE), in Paris, France.
The METRINO consortium exemplifies a unique blend of multidisciplinary expertise, featuring:
Lear more about us by clicking here!
We are committed to:
Learn more about the expected
Fast forward to today, Jan 23rd, 2024, we have just convened our 2nd Project Meeting. Over 40 experts participated online to review our initial findings and strategize for future challenges. Highlights included:
This meeting underscores our commitment to driving innovation and excellence in nanomedicine metrology.
🔔 Stay tuned for more updates as we continue to shape the future of nanomedicine through standardization and characterization!
#METRINO #Nanomedicine #Metrology #Innovation #Collaboration
The METRINO project has received funding from the European Partnership on Metrology (Grant #22HLT04), co-financed from the European Union’s Horizon Europe Research and Innovation Programme and by the Participating States. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or EURAMET. Neither the European Union nor the granting authority can be held responsible for them.